EcoDrugPlus

Atp Binding Cassette Subfamily C Member 9

Ensembl ID : ENSTBEG00000000829
Gene Symbol: ABCC9
1 Cross references
229 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Alpha

Ensembl ID : ENSTBEG00000008848
Gene Symbol: ATP4A
1 Cross references
183 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSTBEG00000010568
Gene Symbol: ATP1A1
1 Cross references
322 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2

Ensembl ID : ENSTBEG00000013159
Gene Symbol: ATP1A2
1 Cross references
205 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 4

Ensembl ID : ENSTBEG00000003427
Gene Symbol: ATP1A4
1 Cross references
564 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSTBEG00000004617
Gene Symbol: ATP1B1
1 Cross references
295 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSTBEG00000005352
Gene Symbol: ATP1B2
1 Cross references
274 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSTBEG00000013815
Gene Symbol: ATR
1 Cross references
206 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSTBEG00000009676
Gene Symbol: AXL
1 Cross references
197 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSTBEG00000011912
Gene Symbol: BRAF
1 Cross references
220 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSTBEG00000011469
Gene Symbol: BCL2L1
1 Cross references
285 Possible Orthologues:

Bcl2 Related Protein A1

Ensembl ID : ENSTBEG00000002955
Gene Symbol: BCL2A1
1 Cross references
114 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).